Abstract
The transformation suppressor gene Pdcd4 (programmed cell death gene 4) inhibits the tumor-promoter mediated transformation of mouse keratinocytes and has recently been implicated as a potential tumor suppressor gene in the development of human lung cancer. Biochemical analysis has suggested that the Pdcd4 protein is involved in protein translation as well as in nuclear events. Recent work has shown that Pdcd4 suppresses the transactivation of AP-1 responsive promoters by c-Jun, suggesting that the transformation-suppressor activity of Pdcd4 might be due, at least in part, to the inhibition of c-Jun activity. Here, we have addressed how Pdcd4 inhibits c-Jun. We show that Pdcd4 interferes with the phosphorylation of c-Jun by Jun N-terminal kinase (JNK). The inhibition of c-Jun phosphorylation by Pdcd4 appears not to be due to a general suppression of JNK activity, our data rather suggest that Pdcd4 interacts with c-Jun and thereby blocks phosphorylation of c-Jun. In addition to affecting c-Jun phosphorylation, Pdcd4 blocks the recruitment of the coactivator p300 by c-Jun. Taken together, our results strongly suggest that Pdcd4 is directly involved in the regulation of c-Jun activity.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 50 print issues and online access
$259.00 per year
only $5.18 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Appl H and Klempnauer K-H . (2002). Oncogene, 21, 3076–3081.
Bannister AJ, Oehler T, Wilhelm D, Angel P and Kouzarides T . (1995). Oncogene, 11, 2509–2514.
Binetruy B, Smeal T and Karin M . (1991). Nature, 351, 122–127.
Böhm M, Sawicka K, Siebrasse JP, Brehmer-Fastnacht A, Peters R. and Klempnauer K-H . (2003). Oncogene, 22, 4905–4910.
Chen Y, Knosel T, Kristiansen G, Pietas A, Garber ME, Matsuhashi S, Ozaki I and Petersen I . (2003). J. Pathol., 200, 640–646.
Cmarik JL, Min H, Hegamyer G, Zhan S, Kulesz-Martin M, Yoshinaga H, Matsuhashi S and Colburn NH . (1999). Proc. Natl. Acad. Sci. USA, 96, 14037–14042.
Dai T, Rubie E, Franklin CC, Kraft A, Gillespie DA, Avruch J, Kyriakis JM and Woodgett JR . (1995). Oncogene, 10, 849–855.
David JP, Ricon M, Neff L, Horne WC and Baron R . (2001). J. Cell. Physiol., 188, 89–97.
Derijard B, Hibi M, Wu IH, Barrett T, Su B, Deng T, Karin M and Davis RJ . (1994). Cell, 76, 1025–1037.
Eckner R, Ewen ME, Newsome D, Gerdes M, DeCaprio JA, Lawrence JB and Livingston DM . (1994). Genes Dev., 8, 869–884.
Fuchs SY, Dolan L, Davis RJ and Ronai Z . (1996). Oncogene, 13, 1531–1535.
Fuchs SY, Xie B, Adler V, Fried VA, Davis RJ and Ronai Z . (1997). J. Biol. Chem., 272, 32163–32168.
Göke A, Göke R, Knolle A, Trusheim H, Schmidt H, Wilmen A, Carmody R, Göke B and Chen YH . (2002). Biochem. Biophys. Res. Commun., 297, 78–82.
Hibi M, Lin A, Smeal T, Minden A and Karin M . (1993). Genes Dev., 7, 2135–2148.
Kallunki T, Deng T, Hibi M and Karin M . (1996). Cell, 87, 929–939.
Kang MJ, Ahn HS, Lee JY, Matsuhashi S and Park WY . (2002). Biochem. Biophys. Res. Commun., 293, 617–621.
Lankat-Buttgereit B and Göke R . (2003). Biol. Cell, 95, 515–519.
Lankat-Buttgereit B, Gregel C, Knolle A, Hasilik A, Arnold R and Göke R . (2004). Mol. Cell. Endocrinol., 214, 149–153.
Lee J-S, See RH, Deng T and Shi Y . (1996). Mol. Cell. Biol., 16, 4312–4326.
Mink S, Haenig B and Klempnauer K-H . (1997). Mol. Cell. Biol., 17, 6609–6617.
Mink S, Kerber U and Klempnauer K-H . (1996). Mol. Cell. Biol., 16, 1316–1325.
Moscovici C, Moscovici MG, Jiminez H, Lai MMC, Hayman MJ and Vog PK . (1977). Cell, 11, 95–103.
Ness SA, Marknell A and Graf T . (1989). Cell, 59, 1115–1125.
Papavassiliou AG, Treier M and Bohmann D . (1995). EMBO J., 14, 2014–2019.
Schlichter U, Burk O, Worpenberg S and Klempnauer K-H . (2001a). Oncogene, 20, 231–239.
Schlichter U, Kattmann D, Appl H, Miethe J, Brehmer-Fastnacht A and Klempnauer K-H . (2001b). Biochim. Biophys. Acta, 1520, 99–104.
Schwartz C, Beck K, Mink S, Schmolke M, Budde B, Wenning D and Klempnauer K-H . (2003). EMBO J., 22, 882–892.
Shibahara K, Asano M, Ishida Y, Aoki T, Koike T and Honjo T . (1995). Gene, 166, 297–301.
Smeal T, Binetruy B, Mercola DA, Birrer M and Karin M . (1991). Nature, 354, 494–496.
Treier M, Staszewski LM and Bohmann D . (1994). Cell, 78, 787–798.
Weiss C, Schneider S, Wagner EF, Zhang X, Seto E and Bohmann D . (2003). EMBO J., 22, 3686–3695.
Yang HS, Cho MH, Zacowicz H, Hegamyer G, Sonenberg N and Colburn N . (2004). Mol. Cell. Biol., 24, 3894–3906.
Yang HS, Jansen AP, Komar AA, Zheng X, Merrick WC, Costes S, Lockett SJ, Sonenberg N and Colburn NH . (2003a). Mol. Cell. Biol., 23, 26–37.
Yang HS, Jansen AP, Nair R, Shibahara R, Verma AK, Cmarik JL and Colburn NH . (2001). Oncogene, 20, 669–676.
Yang HS, Knies JL, Stark C and Colburn NH . (2003b). Oncogene, 22, 3712–3720.
Yoshinaga H, Matsuhashi S, Fujiyama C and Masaki Z . (1999). Pathol. Int., 49, 1067–1077.
Young MR, Yang HS and Colburn NH . (2003). Trends Mol. Med., 9, 36–41.
Acknowledgements
We thank B Michaelis, A Brehmer-Fastnacht and D Wenning for excellent technical assistance and P Angel, D Bohmann, R Davis and E Kerkhoff for plasmids and C Weiss for plasmids and discussions. This work was supported by a grant from the Deutsche Krebshilfe (10-1716) to K-HK.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Bitomsky, N., Böhm, M. & Klempnauer, KH. Transformation suppressor protein Pdcd4 interferes with JNK-mediated phosphorylation of c-Jun and recruitment of the coactivator p300 by c-Jun. Oncogene 23, 7484–7493 (2004). https://doi.org/10.1038/sj.onc.1208064
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.onc.1208064
Keywords
This article is cited by
-
Efficacy of the monocarbonyl curcumin analog C66 in the reduction of diabetes-associated cardiovascular and kidney complications
Molecular Medicine (2022)
-
MicroRNA-21 promotes pancreatic β cell function through modulating glucose uptake
Nature Communications (2022)
-
MicroRNAs as the critical regulators of protein kinases in prostate and bladder cancers
Egyptian Journal of Medical Human Genetics (2021)
-
Reversine inhibits Colon Carcinoma Cell Migration by Targeting JNK1
Scientific Reports (2018)
-
Isoalantolactone Inhibits Esophageal Squamous Cell Carcinoma Growth Through Downregulation of MicroRNA-21 and Derepression of PDCD4
Digestive Diseases and Sciences (2018)